p53 Family in Resistance to Targeted Therapy of Melanoma

Metastatic melanoma is one of the most aggressive tumors, with frequent mutations affecting components of the MAPK pathway, mainly protein kinase BRAF. Despite promising initial response to BRAF inhibitors, melanoma progresses due to development of resistance. In addition to frequent reactivation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Vlašić, Ignacija, Horvat, Anđela, Tadijan, Ana, Slade, Neda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820688/
https://www.ncbi.nlm.nih.gov/pubmed/36613518
http://dx.doi.org/10.3390/ijms24010065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820688/
https://www.ncbi.nlm.nih.gov/pubmed/36613518
http://dx.doi.org/10.3390/ijms24010065

Ejemplares similares